News Sentiment

MGRX sentiment intelligence

Mangoceuticals, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 49 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 0.37 Week of 10 Jul 2026
Weighted tone 49/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-22.3% over one week, +2.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector

Market Reaction

Price moving ahead of tone

57/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction -22.3% Price reacting lower
Trend fit Trend inactive 2.3% over four weeks
Fair value -91.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 31
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 10
Stock Titan 10
TradingKey 3
DirectorsTalk Interviews 2
TipRanks 2
Market source 2
www.marketscreener.com 1
Moomoo 1

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 18
Guidance 3
Regulatory and legal 3
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
TradingView Direct company coverage

Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX

This article provides financial information for Mangoceuticals, Inc. (MGRX), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or a data-focused page from TradingView, indicating no trades and a closed market for the stock at the time of publicati

Tone
Neutral 50/100
Event
Market update
Published
12 Jul 2026 20:11
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Mangoceuticals, Inc. – NASDAQ:MGRX

This article provides the enterprise value to EBITDA forward for Mangoceuticals, Inc. (NASDAQ: MGRX) as displayed on TradingView. It highlights key financial metrics for MGRX, a company in the Pharmaceuticals: Major sub-sector. The data is supported by various financial and refer

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 07:41
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX

The article presents the "price to earnings forward" metric for Mangoceuticals, Inc. (NASDAQ: MGRX). It shows the period, value, change, and percentage change for this financial indicator. The content is primarily a data display from TradingView, including various navigation and

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 09:10
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Mangoceuticals, Inc. – NASDAQ:MGRX

This article displays the title "Enterprise value to revenue forward of Mangoceuticals, Inc. – NASDAQ:MGRX" and some basic financial and market navigation information for Mangoceuticals, Inc. (MGRX). It shows that the market is closed with no trades, and provides links to overvie

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 03:09
Source
TradingView
TradingView Direct company coverage

ETFs Investing in Mangoceuticals, Inc. Stocks

This article lists ETFs that include Mangoceuticals, Inc. (MGRX) stocks in their holdings. It provides details on one specific ETF, the E Fund CSI Shanghai-Hong Kong-Shenzhen 500 ETF, including its market value, weight of MGRX, expense ratio, and performance. The information aims

Tone
Positive 60/100
Event
Market update
Published
04 Jul 2026 03:11
Source
TradingView
Stock Titan Direct company coverage

Mangoceuticals (MGRX) completes $272,000 private placement of common shares

Mangoceuticals, Inc. (MGRX) has completed a private placement, selling 850,000 shares of restricted common stock to an accredited investor at $0.32 per share, totaling $272,000. The transaction, disclosed in an 8-K filing, includes piggyback registration rights for the investor f

Tone
Neutral 50/100
Event
Market update
Published
02 Jul 2026 20:40
Source
Stock Titan
www.marketscreener.com Direct company coverage

Mangoceuticals, Inc. announced that it has received $0.272 million in funding

Mangoceuticals, Inc. has secured $0.272 million in funding through a subscription agreement with an accredited investor. The company issued 850,000 shares of restricted common stock at $0.32 per share, availing an exemption from registration under the securities act. This funding

Tone
Positive 66/100
Event
Market update
Published
29 Jun 2026 16:11
Source
www.marketscreener.com
Moomoo Direct company coverage

Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market

Mangoceuticals (OTC: MNGOC) stock saw a significant 41.16% increase in post-market trading today, reaching $0.0031. This surge occurred despite the company not releasing any specific news or updates, suggesting market speculation or technical trading movements as potential driver

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 21:09
Source
Moomoo
TradingKey Direct company coverage

Mangoceuticals Inc (MGRX) Institutional Confidence

This article from TradingKey provides an overview of institutional confidence in Mangoceuticals Inc (MGRX), including its stock price, market cap, and various analytical dimensions. It details the institutional shareholding, listing key holders like Armistice Capital LLC and Cohe

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 21:40
Source
TradingKey
TradingKey Direct company coverage

Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Mangoceuticals Inc (MGRX) stock, focusing on its dividend history and stock split events. It indicates that MGRX has not distributed dividends in the past five years and lists several merger events scheduled for October 11, 2024, with a 15:1 ra

Tone
Neutral 50/100
Event
Deals and strategy
Published
17 Jun 2026 13:10
Source
TradingKey
TradingKey Direct company coverage

Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Mangoceuticals Inc (MGRX), though it states that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. It briefly shows the stock's current mar

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 12:10
Source
TradingKey
Simply Wall Street Direct company coverage

Mangoceuticals (Nasdaq:MGRX) - Stock Analysis

Mangoceuticals, Inc. (Nasdaq:MGRX) is a company specializing in men's wellness products and services delivered via a telemedicine platform. The stock analysis highlights significant risks including shareholder dilution, declining earnings and revenue, a small market capitalizatio

Tone
Negative 8/100
Event
Earnings
Published
03 Jun 2026 15:40
Source
Simply Wall Street
Finviz Direct company coverage

MGRX - Mangoceuticals Inc Stock Price and Quote

This article provides a detailed overview of Mangoceuticals Inc. (MGRX) stock, including its current price, financial metrics, performance indicators, and recent news headlines. It covers market capitalization, sales, earnings per share, insider transactions, and a chronological

Tone
Neutral 50/100
Event
Earnings
Published
01 Jun 2026 15:10
Source
Finviz
Intellectia AI Direct company coverage

MGRX Technical Analysis & Stock Price Forecast

This article provides a technical analysis and stock price forecast for Mangoceuticals Inc (MGRX) as of June 1, 2026. It indicates an overall Neutral technical sentiment based on various indicators, with some suggesting buy and others sell. The analysis covers moving averages, mo

Tone
Neutral 50/100
Event
Guidance
Published
01 Jun 2026 14:09
Source
Intellectia AI
TradingView Direct company coverage

Number of shareholders of Mangoceuticals, Inc. – NASDAQ:MGRX

This article displays the number of shareholders for Mangoceuticals, Inc. (NASDAQ: MGRX) as retrieved from TradingView. It provides a quick overview, but the specific numerical value for shareholders is not explicitly stated in the provided content. The article is part of Trading

Tone
Neutral 50/100
Event
Market update
Published
30 May 2026 17:08
Source
TradingView
Stock Titan Direct company coverage

Mangoceuticals (NASDAQ: MGRX) Q1 2026 shows small sales, heavy loss and thin cash

Mangoceuticals Inc. reported a Q1 2026 net loss of $3.4 million on revenues of $67,864, down from the prior year, with significant spending on operations and stock-based compensation. The company's cash and cash equivalents dwindled to $174,562, highlighting severe liquidity conc

Tone
Negative 15/100
Event
Balance sheet
Published
20 May 2026 08:39
Source
Stock Titan
TradingView Direct company coverage

MANGOCEUTICALS, INC. 1Q 2026: Revenue $67.9K, EPS $(0.22) — 10-Q Summary

MANGOCEUTICALS, INC. (MGRX) reported its first-quarter 2026 results, showing a revenue of $67.9K, a decrease from the prior year, and a net loss of $3.7M. Despite the revenue decline, the company narrowed its loss per share to $(0.22). Key business activities included advancing w

Tone
Neutral 50/100
Event
Earnings
Published
19 May 2026 20:39
Source
TradingView
TradingView Direct company coverage

MGRX: Net loss narrowed but liquidity and Nasdaq compliance risks persist, requiring urgent funding

MGRX experienced a decline in revenue and a narrowed net loss year-over-year, attributed to its focus on product testing and website development. However, the company faces ongoing financial losses, regulatory challenges, and Nasdaq compliance issues, underscoring an urgent need

Tone
Negative 19/100
Event
Earnings
Published
19 May 2026 20:39
Source
TradingView
TipRanks Direct company coverage

Mangoceuticals Delays Quarterly Filing After Audit Review

Mangoceuticals, Inc. (MGRX) has announced a delay in filing its Form 10-Q for the quarter ended March 31, 2026, due to additional time required by its independent auditor for review. The company expects to file within the five-day grace period and does not anticipate significant

Tone
Negative 38/100
Event
Earnings
Published
15 May 2026 23:09
Source
TipRanks
MSN Direct company coverage

Mangoceuticals stock doubles after Texas lawsuit

Mangoceuticals (MNGO) stock surged by an unspecified percentage following a legal victory in Texas. The company announced the successful resolution of its lawsuit against its former Chief Executive Officer. This news led to a significant increase in investor confidence and the st

Tone
Positive 95/100
Event
Regulatory and legal
Published
14 Apr 2026 16:09
Source
MSN
MarketBeat Direct company coverage

MGRX Q4 2025 Earnings Report on 4/1/2026

This article details the Q4 2025 earnings report for Mangoceuticals (NASDAQ: MGRX), released on April 1, 2026. The company reported $0.13 Actual EPS and $0.09 million in Actual Revenue, with both consensus EPS and expected revenue listed as N/A. The report also highlights recent

Tone
Neutral 50/100
Event
Earnings
Published
01 Apr 2026 13:39
Source
MarketBeat
TradingView Direct company coverage

Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17)

Mangoceuticals (MGRX) reported annual revenue of $0.456 million and an EPS loss of $(2.17) for the year, primarily due to issues during a telemedicine platform relaunch. The company posted a significant net loss of $(20.643) million, driven by increased stock-based compensation,

Tone
Negative 28/100
Event
Earnings
Published
01 Apr 2026 10:10
Source
TradingView
TipRanks Direct company coverage

Mangoceuticals Delays Annual 10-K Yearly Filing

Mangoceuticals, Inc. (MGRX) has announced a delay in filing its 2025 Form 10-K Yearly Report, attributing the hold-up to its external auditor needing additional time for review. The company expects to file within the 15-day grace period from the original March 31, 2026 due date a

Tone
Negative 40/100
Event
Guidance
Published
01 Apr 2026 02:10
Source
TipRanks